- KDSTEM Selected for the 2024 Korean Fund for Regenerative Medicine (KFRM) Program
- ADSTEM IND application submitted for Phase 3 clinical trial in atopic dermatitis
COMPANY
We contribute to promoting human health.
We are the global leader in stem cell therapies
The effort of EHL BIO to create a new future continues.
- KDSTEM Selected for the 2024 Korean Fund for Regenerative Medicine (KFRM) Program
- ADSTEM IND application submitted for Phase 3 clinical trial in atopic dermatitis
- KDSTEM IND approved and initiated for Phase 1 clinical trial in chronic kidney disease
- ADSTEM Completed Phase 2 clinical trial in atopic dermatitis
- KDSTEM Selected for the 2022 Korean Fund for Regenerative Medicine (KFRM) Program
- Signed MOU for Advanced Regenerative Medicine Agreement (Hwasun Chonnam National University Hospital, Gangnam Severance Hospital, New Breath Hospital)
- EHLBio Cell Center relocation to Apgujeong
- Permission for human cell management business(No. 1)
- CPC(Cell Processing Center) Permission for the 1st time in Korea
- Signed MOU for advanced regenerative medicine
(Chungnam National University Hospital,
Dankook University Hospital, Chonnam National University Hospital,
Seoul Songdo Hospital)
Establishment of subsidiary EHL CELLTECH
Phase 2 clinical trials approval for
ADSTEM(the first in Korea, self adipose-derived, intravenous injection)
Opening of a Cambodian branch and a hospital specializing
in cell therapy(Joint company)
Completion of 2nd GMP(500 LOT per month can be cultured.)
Opening a local office in Indonesia
Phase 2 clinical trials application for ADSTEM
Establishment of Stem-heal Society.
2017.12 Phase 1 clinical trials completed for ADSTEM.
2017.11 Signed ODA Clinic for Cooperation in Japan.
2017.09 Establishment of representative office in Vietnam
2017.07 CPC approval by the Japanese Ministry of Health and welfare.
2017.06 Safety test completed for immune cell preclinical test.
Selected for Start-up Growth Technology Development Project
by Ministry of SMEs(Small and Medium-sized Enterprises) and startups.
Preclinical test for immune cell.
Approved Clinic Phase I
Applying for clinical trials of Self adipose-derived
stem cells/Vascular injection/Atopic dermatitis.
Expand and relocate research institutes.
Certified as Venture Company(‘15.03)
Registered Company Research Center
Selected for Industry-Academic Cooperation Technology Development
Projects of Ministry of SMEs(Small and Medium-sized Enterprises) and startups.
Preclinical test for ADSTEM injection that is atopic dermatitis treatment.
Launch of stem cell culture fluid cosmetics, hair growth test by culture fluid,
research for development of culture medium for healthcare.
Founded EHL Bio, Co., Ltd